1. Home >
  2. M&A >
  3. Venture >
  4. Switzerland >
  5. Edmond de Rothschild Private Equity Invests In OncoEthix SA

Investment Summary

Edmond de Rothschild Private Equity Invests In OncoEthix SA

On July 9, 2013, private equity firm Edmond de Rothschild Private Equity invested in life science company OncoEthix SA

Investment Highlights
  • This is Edmond de Rothschild Private Equity’s 5th transaction in the Life Science sector.
  • This is Edmond de Rothschild Private Equity’s 3rd transaction in Switzerland.
Investment Fate
  • OncoEthix SA was sold to a publicly-traded strategic buyer in 2014 for 110M USD.

Investment Summary
Date 2013-07-09
Target OncoEthix SA
Sector Life Science
Investor(s) Edmond de Rothschild Private Equity
Deal Type Venture

Target

OncoEthix SA

Lausanne, Switzerland
OncoEthix is a privately held biotechnology company aiming to develop a small portfolio of oncology drug candidates. The Company’s lead product, OTX015, is an investigational orally administered synthetic small molecule targeted to BET bromodomain proteins 2/3/4. OTX015 was in-licensed from Mitsubishi Tanabe Pharma Corporation in March 2012 following completion of Phase I clinical studies in healthy volunteers.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Edmond de Rothschild Private Equity

Investor

Category Private Equity Firm
Founded 2014
PE ASSETS 4.3B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Edmond de Rothschild Private Equity is the private equity arm of asset manager and financial services firm Edmond de Rothschild. The private equity group looks seeks buyout and expansion style investments and will consider opportunities across the world, including North America, Europe, and Africa. The Firm broadly invests in real estate, infrastructure projects, and directly in companies. Edmond de Rothschild Private Equity is based in Geneva, Switzerland.

DEAL STATS #
Overall 22 of 31
Sector: Life Science M&A 5 of 7
Type: Venture M&A Deals 4 of 5
Country: Switzerland M&A 3 of 3
Year: 2013 M&A 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-07-04 Prozone Sports

Leeds, United Kingdom

Prozone Sports Ltd. is a provider of software tools for sport performance analysis.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-09-19 Mediascience

Evreux, France

Mediascience is specializing in design and distribution of scientific equipment. Mediascience was founded in 2002 and is based in Evreux, France.

Sell -
Mergr

Solution for

Product

Company

Legal